The Patent Finder

Archemix Corp.

Also on record
Records under this name other than the patents Archemix Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Archemix Corp.

PatentTitleStatus Expires Confidence
US 8,252,913Aptamers to Tissue Factor Pathway Inhibitor and Their Use as Bleeding Disorder Therapeutics
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,236,773Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Formerly held
Term ended
Term ended Nov 11, 2026 · Medium confidence
Term endedTerm ended Nov 11, 2026Medium confidence
US 10,100,316Aptamers comprising CPG motifs
Term ended
Term ended Jul 26, 2025 · From the USPTO record
Term endedTerm ended Jul 26, 2025From the USPTO record
US 11,913,000Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Formerly held
Term ended
Term ended Apr 25, 2025 · Medium confidence
Term endedTerm ended Apr 25, 2025Medium confidence
US 7,538,211Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Formerly held
Term ended
Term ended Feb 14, 2025 · High confidence
Term endedTerm ended Feb 14, 2025High confidence
US 7,579,456Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Formerly held
Term ended
Ended no later than Feb 14, 2025 · Low confidence
Term endedEnded no later than Feb 14, 2025Low confidence
US 7,803,931Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Formerly held
Term ended
Term ended Feb 14, 2025 · Medium confidence
Term endedTerm ended Feb 14, 2025Medium confidence
US 8,436,164Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Formerly held
Term ended
Term ended Feb 14, 2025 · High confidence
Term endedTerm ended Feb 14, 2025High confidence
US 9,617,546Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Formerly held
Term ended
Ended no later than Feb 14, 2025 · Low confidence
Term endedEnded no later than Feb 14, 2025Low confidence
US 10,947,544Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Formerly held
Term ended
Term ended Feb 14, 2025 · Medium confidence
Term endedTerm ended Feb 14, 2025Medium confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited